IFNG and neoplasm: Tumour-induced glucose restriction in the TME reduces NK cell glycolysis and disrupts normal NK cell effector functions, such as interferon-gamma (IFN-γ) production and target cell damage, ultimately suppressing antitumour capacity (128–132).